PolyPeptide Group AG (PPGN)

Switzerland
65.35
-0.45(-0.68%)
  • Volume:
    10,496
  • Bid/Ask:
    65.20/65.45
  • Day's Range:
    64.00 - 66.15
  • Type:Equity
  • Market:Switzerland
  • ISIN:CH1110760852
  • S/N:111076085

PPGN Overview

Prev. Close
65.8
Day's Range
64-66.15
Revenue
286.22M
Open
66.1
52 wk Range
60.55-147.4
EPS
1.47
Volume
10,496
Market Cap
2.18B
Dividend (Yield)
0.30
(0.46%)
Average Volume (3m)
35,112
P/E Ratio
44.45
Beta
-
1-Year Change
-23.84%
Shares Outstanding
33,104,630
Next Earnings Date
-
What is your sentiment on PolyPeptide Group AG?
or
Vote to see community's results!

PolyPeptide Group AG Company Profile

PolyPeptide Group AG Company Profile

PolyPeptide Group AG operate as a contract development and manufacturing company worldwide. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development, and in generic products. It engages in manufacturing custom research grade peptides; and developing neoantigen peptide to support personalized cancer therapies. The company is also involved in manufacturing peptides for commercially approved peptide therapeutics. In addition, it manufactures peptide-based generics for human and veterinary markets; and cosmetic peptides. Further, the company offers regulatory affair support services. The company was founded in 1952 and is headquartered in Zug, Switzerland. PolyPeptide Group AG is a subsidiary of Draupnir Holding B.V.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuySellStrong SellSell
Technical IndicatorsStrong BuyStrong BuySellStrong SellStrong Sell
SummaryStrong BuyStrong BuySellStrong SellStrong Sell